Journey Advisory Group’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-903
Closed -$337K 278
2024
Q4
$337K Hold
903
0.04% 183
2024
Q3
$337K Buy
903
+65
+8% +$23.1K 0.04% 183
2024
Q2
$313K Sell
838
-357
-30% -$121K 0.04% 186
2024
Q1
$414K Sell
1,195
-360
-23% -$136K 0.05% 174
2023
Q4
$712K Sell
1,555
-246
-14% -$121K 0.1% 124
2023
Q3
$876K Sell
1,801
-45
-2% -$21.1K 0.13% 116
2023
Q2
$825K Sell
1,846
-715
-28% -$360K 0.12% 120
2023
Q1
$1.24M Sell
2,561
-1,691
-40% -$836K 0.2% 103
2022
Q4
$2.18M Sell
4,252
-865
-17% -$455K 0.54% 54
2022
Q3
$2.48M Sell
5,117
-285
-5% -$139K 0.63% 41
2022
Q2
$2.56M Sell
5,402
-365
-6% -$162K 0.59% 43
2022
Q1
$2.51M Sell
5,767
-250
-4% -$105K 0.64% 38
2021
Q4
$2.79M Sell
6,017
-64
-1% -$28.3K 0.77% 32
2021
Q3
$2.37M Sell
6,081
-144
-2% -$61.1K 0.77% 30
2021
Q2
$2.76M Sell
6,225
-25
-0.4% -$10.9K 0.88% 30
2021
Q1
$2.62M Buy
6,250
+100
+2% +$39.9K 0.92% 29
2020
Q4
$2.52M Buy
+6,150
New +$2.56M 0.94% 30

Other funds holding HUM

Journey Advisory Group's HUM Position: Q1 2025 in Review

Journey Advisory Group sold out of Humana (HUM) in Q1 2025, closing a stake of 903 shares — an estimated $337K sold.

Journey Advisory Group first reported a position in HUM in Q4 2020 and held it in 17 quarters. The position peaked at $2.79M in Q4 2021. 902 funds tracked by Wall St. Rank hold HUM as of Q1 2025.

  • Journey Advisory Group reported no remaining Humana position as of Q1 2025 after selling out during the quarter.
  • Journey Advisory Group sold 903 Humana shares in Q1 2025, an estimated $337K.
  • Journey Advisory Group first reported a position in Humana in Q4 2020 and held it in 17 quarters.
  • Journey Advisory Group's Humana position peaked at $2.79M in Q4 2021.
  • 902 funds tracked by Wall St. Rank held Humana as of Q1 2025.

Based on Journey Advisory Group's 13F filing for Q1 2025, filed 13 May 2025.